Biosimilar Drug Product Development
Redigert av . Paul Declerck, Shein-Chung Chow, Laszlo Endrenyi, 2020.Del av serien Drugs and the Pharmaceutical Sciences.
When a biological drug patent expires, alternative biosimilar products are developed. The development of biosimilar products is complicated and involves numerous considerations and steps. The assessment of biosimilarity and interchangeability is also complicated and difficult. Biosimilar Drug Product Development presents current issues for the development of biosimilars and gives detailed reviews of its various stages and contributing factors as well as relevant regulatory pathways and pre- and post-approval issues.
Språk: Engelsk
Ikke tilgjengelig for Klikk&Hent
Midlertidig tomt på lager
Bestillingsvare. Forventes sendt om ca 8 dager
Oppdag mer
Biosimilar Drug Product Development
Redigert av . Paul Declerck, Shein-Chung Chow, Laszlo Endrenyi, 2020.Del av serien Drugs and the Pharmaceutical Sciences.
When a biological drug patent expires, alternative biosimilar products are developed. The development of biosimilar products is complicated and involves numerous considerations and steps. The assessment of biosimilarity and interchangeability is also complicated and difficult. Biosimilar Drug Product Development presents current issues for the development of biosimilars and gives detailed reviews of its various stages and contributing factors as well as relevant regulatory pathways and pre- and post-approval issues.
Oppdag mer
Språk: Engelsk
Ikke tilgjengelig for Klikk&Hent
Midlertidig tomt på lager
Bestillingsvare. Forventes sendt om ca 8 dager
Ved å fullføre kjøpet aksepterer du kjøpsvilkårene.
